Edition:
United Kingdom

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

15.70USD
13 Jul 2018
Change (% chg)

$-0.15 (-0.95%)
Prev Close
$15.85
Open
$15.90
Day's High
$16.00
Day's Low
$15.70
Volume
18,684
Avg. Vol
65,122
52-wk High
$17.05
52-wk Low
$13.35

Chart for

About

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $620.38
Shares Outstanding(Mil.): 42.20
Dividend: 0.12
Yield (%): 3.40

Financials

  VIVO.OQ Industry Sector
P/E (TTM): 29.32 32.18 32.76
EPS (TTM): 0.50 -- --
ROI: 9.27 13.91 14.61
ROE: 12.68 16.75 16.34

BRIEF-Meridian Bioscience Reports Q2 GAAP EPS Of $0.12

* MERIDIAN BIOSCIENCE REPORTS SECOND QUARTER 2018 OPERATING RESULTS, DECLARES REGULAR SECOND QUARTER CASH DIVIDEND, AND UPDATES FISCAL 2018 GUIDANCE

26 Apr 2018

BRIEF-Meridian Bioscience Reports Q1 GAAP EPS Of $0.15

* MERIDIAN BIOSCIENCE REPORTS FIRST QUARTER 2018 OPERATING RESULTS, DECLARES REGULAR FIRST QUARTER CASH DIVIDEND, AND REAFFIRMS FISCAL 2018 GUIDANCE

25 Jan 2018

Earnings vs. Estimates